文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

循环单核细胞计数对严重脓毒症(含脓毒性休克)患者结局的影响

Circulating Monocyte Counts and its Impact on Outcomes in Patients With Severe Sepsis Including Septic Shock.
PubMed 文献 · Shock · 2019-01-01
一句话结论严重脓毒症患者初始单核细胞计数<250 cells/μL与最高28天死亡率、菌血症率和器官功能障碍相关,且非幸存者从病前到脓毒症时单核细胞计数下降。

该回顾性分析纳入2012例严重脓毒症(含脓毒性休克)患者,按初始单核细胞计数分为<250、250-500、500-750和≥750 cells/μL四组,比较28天死亡率、菌血症率和器官功能障碍。多因素logistic回归显示仅单核细胞计数与死亡率独立相关,<250 cells/μL组死亡率、菌血症率和器官功能障碍最高。在有病前血细胞计数数据的亚组中,幸存者从病前到脓毒症时单核细胞计数升高,而非幸存者下降。结论提示单核细胞计数与脓毒症患者不良结局相关,可能与非幸存者单核细胞生成相对不足有关。

要点

  • 初始单核细胞计数<250 cells/μL的严重脓毒症患者28天死亡率、菌血症率和器官功能障碍最高。
  • 多因素logistic回归中,仅单核细胞计数与28天死亡率独立相关,中性粒细胞计数无独立关联。
  • 有病前血细胞计数数据的患者中,幸存者从病前到脓毒症时单核细胞计数升高,非幸存者下降。
  • 幸存者与非幸存者的中性粒细胞和单核细胞计数均有显著差异,但仅单核细胞计数具独立预后价值。

适用人群与场景

  • 严重脓毒症包括脓毒性休克的患者(回顾性分析人群)。

诊断标准与关键阈值

  • 单核细胞计数分组界值:<250 cells/μL、250-500 cells/μL、500-750 cells/μL、≥750 cells/μL。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量:2012例严重脓毒症(含脓毒性休克)患者。
  • 主要结果:初始单核细胞计数<250 cells/μL组28天死亡率、菌血症率和器官功能障碍最高。
  • 多因素logistic回归:仅单核细胞计数与28天死亡率独立相关,中性粒细胞计数无独立关联。
  • 亚组分析(有病前血细胞计数数据):幸存者从病前到脓毒症时单核细胞计数升高,非幸存者下降。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为单核细胞计数与脓毒症患者死亡率、菌血症率和器官功能障碍相关,可能因非幸存者单核细胞生成相对不足所致。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

This study was performed to evaluate the association of monocyte counts with mortality, the rate of bacteremia, and organ dysfunction and to evaluate whether the change in monocyte counts from the premorbid state to sepsis would differ between survivors and non-survivors in patients with severe sepsis including septic shock. A retrospective analysis of patients with severe sepsis including septic shock was performed. Monocyte counts were categorized into <250, 250-500, 500-750, and ≥750 cells/μL; in addition, 28-day mortality, the rate of bacteremia, and organ dysfunction were compared between the groups. Multivariate logistic regression analyses were performed to evaluate the independent association of initial blood cell counts with 28-day mortality. Subgroup analyses of patients who had premorbid data of blood cell counts were performed to evaluate the difference in the change in monocyte counts between survivors and non-survivors. During the study period, 2,012 patients were included. Neutrophil and monocyte counts were significantly different between survivors and non-survivors. However, only monocyte counts were independently associated with mortality in the multivariate logistic regression analyses. Patients with initial monocyte counts <250 cells/μL showed the highest mortality, rate of bacteremia, and organ dysfunction. In patients who had premorbid blood cell counts, the monocyte counts increased in survivors but decreased in non-survivors from the premorbid to sepsis. In conclusion, monocyte counts were associated with mortality, the rate of bacteremia, and organ dysfunction in patients with sepsis, possibly due to the relative lack of monocytopoiesis related to septic insults in non-survivors.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Chung H, Lee JH, Jo YH, et al. Circulating Monocyte Counts and its Impact on Outcomes in Patients With Severe Sepsis Including Septic Shock. Shock. 2019. PMID: 30286035. doi:10.1097/SHK.0000000000001193

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。